Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19" has been added to ResearchAndMarkets.com's offering.
The clinical laboratory sector significantly rose to the challenge presented by COVID-19, triggering a transformation that has persisted beyond the pandemic. As Point of Care and Self Testing gain prominence, there's a shifting dynamic threatening the traditional demand for clinical lab services. However, the ascent of Molecular Diagnostics is propelling substantial growth within the industry. This comprehensive report delves into both opportunities and potential threats.
Despite these shifts, the foundational elements that bolster clinical laboratory testing remain robust. The sector is poised to capitalize on the burgeoning biotechnology field, particularly genomics. A variety of dynamic trends are fueling market expansion and enhancing company valuations.
Key Trends Influencing Growth:
- The genetic blizzard
- Emerging economies and increasing global prosperity
- Pharmacogenomics
- Healthcare expansion in China
- Climate change
- Globalization
- Automation
Noteworthy technical advancements, particularly in molecular diagnostics and pharmacogenomics, promise a vibrant, expanding, and evolving global market. These advancements signal a shift from national and regional focuses to a more interconnected global perspective.
Our report equips analysts and planners with substantial data. It includes extensive details such as a comprehensive list of the current United States Medicare Fee Payment Schedules, which aid in pricing strategies. The data facilitates planning for facilities, forecasting demand for new testing regimes, and making informed research investment decisions. With thorough primary and secondary research, testing volume data is dissected into pricing and volumes, enabling quick, informed forecasting of demand. Existing labs and hospitals can directly apply this information to forecast and strategize clinical facility growth.
Coverage in the report extends to detailed analyses of 15 countries and 4 regions, along with five-year market forecasts.
Key Topics Covered:
1 Market Guides
- 1.1 Clinical Laboratory Services - Strategic Situation Analysis and Covid -19 Impact
- 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
- 1.3 Guide for Management Consultants and Investment Advisors
2 Introduction and Market Definition
- 2.1 The Growing Demand for Clinical Testing
- 2.2 Defining the Opportunity
- 2.3 Methods and Sources
- 2.4 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
3 Overview of a Dynamic Market
- 3.1 Players in a Dynamic Market
- 3.2 Segmentation - Different Approaches
- 3.3 Structure of Clinical Testing Industry
- 3.4 National and Regional Diversity
4 Trends Driving a Changing Market
- 4.1 Growth Is Pushed from Many Sides
- 4.2 Factors at Work to Shrink the Market
- 4.3 Automation
- 4.4 Environment and Evolution
- 4.5 Diagnostic Technology Development
5 Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
- 5.1 Recent Developments - Importance and How to Use This Section
- 5.2 Seegene to Enter Syndromic MDx Space
- 5.3 EKF Diagnostics Acquires Advanced Diagnostic Laboratory
- 5.4 Molecular Health, EDGC Ink Liquid Biopsy Partnership
- 5.5 ProPhase Labs Acquires Nebula Genomics for $14.6M
- ...
- 5.23 BioReference Laboratories selected by IPA Association
6 Profiles of Key Companies
- 6.1 Acibadem Labmed Laboratory
- 6.2 ACM Medical Laboratory
- 6.3 Adicon Clinical Laboratories
- ...
- 6.43 Unilabs
7 The Global Market for Clinical Laboratory Testing
- 7.1 Global Market Overview by Country
- 7.2 Global Market by Assay Type - Overview
8 Global Clinical Laboratory Diagnostic Markets - By Assay Type
- 8.1 Chemistry
- 8.2 Microbiology
- 8.3 Hematology
- 8.4 Anatomic Pathology
- 8.5 Covid-19
- 8.6 Molecular Diagnostics
9 Global Clinical Laboratory Diagnostic Markets - Price and Volume Charts
- 9.1 Chemistry Price and Volume
- 9.2 Microbiology Price and Volume
- 9.3 Hematology Price and Volume
- 9.4 Anatomic Pathology Price and Volume
- 9.5 Covid-19 Price and Volume
- 9.6 Molecular Diagnostics Price and Volume
10 The Future of the Clinical Laboratory
Companies Featured
- Acibadem Labmed Laboratory
- ACM Medical Laboratory
- Adicon Clinical Laboratories
- American Bio-Clinical Laboratories, Int'l
- American Pathology Partners
- ARUP Laboratories
- Ascend Clinical
- Assurance Scientific Laboratories
- Aurora Diagnostics
- Bio-Reference Laboratories
- Bioscientia Institut fur Medizinische Diagnostik GmbH
- BP Healthcare Group
- Clinical Reference Laboratory
- Clongen Laboratories
- CompuNet Clinical Laboratories
- Diagnosticos da America
- DIAN Diagnostics Co., Ltd.
- Enzo Biochem
- Eone Laboratories
- Eurofins Scientific
- Exagen Diagnostics
- Genzyme Corporation
- Gribbles Pathology
- Guangzhou Kingmed Diagnostics Group Co., Ltd.
- Integrated Regional Laboratories
- KDL Group
- Laboratory Corporation of America
- Lifelabs
- Mayo Clinic Laboratories
- Mid America Clinical Laboratories
- MNG Labs
- Myriad Genetics/Myriad RBM
- NeoGenomics
- OncoDNA
- Pathology, Inc.
- ProPhase Labs
- Psychemedics Corporation
- Quest Diagnostics
- RDL Reference Laboratory
- Sonic Healthcare
- Spectra Laboratories
- Sysmex Inostics
- Unilabs
For more information about this report visit https://www.researchandmarkets.com/r/m1bqfu
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
